N370S‐GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease

Background Heterozygous mutations in the GBA1 gene, which encodes the lysosomal enzyme β‐glucocerebrosidase‐1, increase the risk of developing Parkinson's disease, although the underlying mechanisms remain unclear. The aim of this study was to explore the impact of the N370S‐GBA1 mutation on ce...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders Vol. 32; no. 10; pp. 1409 - 1422
Main Authors: García‐Sanz, Patricia, Orgaz, Lorena, Bueno‐Gil, Guillermo, Espadas, Isabel, Rodríguez‐Traver, Eva, Kulisevsky, Jaime, Gutierrez, Antonia, Dávila, José C., González‐Polo, Rosa A., Fuentes, José M., Mir, Pablo, Vicario, Carlos, Moratalla, Rosario
Format: Journal Article
Language:English
Published: United States Wiley Subscription Services, Inc 01-10-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Heterozygous mutations in the GBA1 gene, which encodes the lysosomal enzyme β‐glucocerebrosidase‐1, increase the risk of developing Parkinson's disease, although the underlying mechanisms remain unclear. The aim of this study was to explore the impact of the N370S‐GBA1 mutation on cellular homeostasis and vulnerability in a patient‐specific cellular model of PD. Methods We isolated fibroblasts from 4 PD patients carrying the N370S/wild type GBA1 mutation and 6 controls to study the autophagy‐lysosome pathway, endoplasmic reticulum stress, and Golgi apparatus structure by Western blot, immunofluorescence, LysoTracker and Filipin stainings, mRNA analysis, and electron microscopy. We evaluated cell vulnerability by apoptosis, reactive oxygen species and mitochondrial membrane potential with flow cytometry. Results The N370S mutation produced a significant reduction in β‐glucocerebrosidase‐1 protein and enzyme activity and β‐glucocerebrosidase‐1 retention within the endoplasmic reticulum, which interrupted its traffic to the lysosome. This led to endoplasmic reticulum stress activation and triggered unfolded protein response and Golgi apparatus fragmentation. Furthermore, these alterations resulted in autophagosome and p62/SQSTM1 accumulation. This impaired autophagy was a result of dysfunctional lysosomes, indicated by multilamellar body accumulation probably caused by increased cholesterol, enlarged lysosomal mass, and reduced enzyme activity. This phenotype impaired the removal of damaged mitochondria and reactive oxygen species production and enhanced cell death. Conclusions Our results support a connection between the loss of β‐glucocerebrosidase‐1 function, cholesterol accumulation, and the disruption of cellular homeostasis in GBA1‐PD. Our work reveals new insights into the cellular pathways underlying PD pathogenesis, providing evidence that GBA1‐PD shares common features with lipid‐storage diseases. © 2017 International Parkinson and Movement Disorder Society
Bibliography:This work was supported by grants from the Spanish Ministeries of Economía y Competitividad, Sanidad Política Social e Igualdad and ISCIII CIBERNED: SAF2016‐78207‐R, PCIN2015‐098, CB06/05/0055 and PI2015‐2/02 (to R.M.); SAF2013‐4759R and CB06/05/0065 (to C.V.); CB06/05/004 and PI15/00034 and Junta de Extremadura: GR15045 (to J.M.F.); FIS PI14/00170 to RA G‐P; FIS PI15/00796 (to A.G.); La Caixa and Marató TV3 (to J.K.). J.K. has received honoraria for lectures and/or advisory boards from AbbVie, Zambon, UCB, Italfarmaco, and TEVA. E.R.T., L.O., I.E., and G.B.G. were supported by FPI and FPU fellowships from MINECO and MECD. RA G‐P was supported by the Contract for the Retention and Attraction of Talent Researcher of the Government of Extremadura, TA13009 (Junta de Extremadura, Spain). P.M. has been supported by grants from the Instituto de Salud Carlos III‐Fondo Europeo de Desarrollo Regional (PI16/01575), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI‐02526, CTS‐7685), the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI‐0471/2013), the Sociedad Andaluza de Neurología, the Fundación Alicia Koplowitz, and the Fundación Mutua Madrileña.
Nothing to report.
Relevant conflicts of interests/financial disclosures
Funding agencies
Rosario Moratalla and Carlos Vicario contributed equally to this article.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.27119